Rallybio Corporation (RLYB)
RLYB trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$16.72
-0.42% on the day
Market cap
$88.8M
Micro cap
Revenue · 2025
$858K
+34.9% on 2024
Net income · 2025
-$9.0M
-1046.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RLYB on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001739410 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $858K |
| Net income | -$9.0M |
| Operating income | -$33.1M |
| Net margin | -1046.4% |
| Operating margin | -3853.6% |
| Revenue growth | +34.9% |
| Cash | $31.4M |
| Total assets | $62.3M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 103.5× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2025-03-13 |
| Latest annual report | 10-K | 2026-03-16 |
| Latest quarterly / interim | 10-Q | 2026-08-06 |
| Latest current report | 8-K | 2026-09-09 |
| Latest proxy | DEF 14A | 2026-01-02 |
Source: SEC EDGAR submissions feed, 290 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AARD | Aardvark Therapeutics Inc. | $4.04 | -9.21% | $88.4M |
| BMEA | Biomea Fusion Inc. | $1.26 | -7.35% | $91.3M |
| RTSN | Retension Pharmaceuticals Inc. | $11.63 | +2.74% | $91.7M |
| CRBP | Corbus Pharmaceuticals Holdings Inc. | $4.78 | -9.30% | $92.5M |
| ANIX | Anixa Biosciences Inc. | $2.67 | -5.99% | $92.8M |
| IMUX | Immunic Inc. | $6.89 | -13.33% | $94.0M |
| EQ | Equillium Inc. | $1.32 | -12.00% | $83.7M |
| OKUR | OnKure Therapeutics Inc. | $2.35 | -3.10% | $95.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier